524743 — Fischer Medical Ventures Income Statement
0.000.00%
Last trade - 00:00- IN₹56.67bn
- IN₹55.01bn
- IN₹1.11bn
Annual income statement for Fischer Medical Ventures, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1.65 | 0 | 1.79 | 210 | 1,107 |
| Cost of Revenue | |||||
| Gross Profit | — | — | — | 45.3 | 191 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1.83 | 1.89 | 1.64 | 193 | 1,090 |
| Operating Profit | -0.176 | -1.89 | 0.152 | 16.8 | 16.8 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.356 | -1.97 | -0.013 | 21.1 | 22.2 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 1.41 | -2.33 | -0.365 | 18.4 | 12.1 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 1.41 | -2.33 | -0.365 | 18.4 | 12.1 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 1.41 | -2.33 | -0.365 | 18.4 | 12.1 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 8.18 | -13.5 | -2.12 | 1.65 | 0.22 |
| Dividends per Share |